Using insect cells, scientists in Vienna have developed an alternative method for producing the H1N1 vaccine. The researchers say the discovery, detailed in the Biotechnology Journal, will aid the fight against influenza pandemics by speeding up production and making it easier to meet the demand for vaccines.
"Recent outbreaks of influenza highlight the importance of a rapid and sufficient vaccine supply for pandemic and inter pandemic strains," said co-author Florian Krammer from the University of Natural Resources and Applied Life Science in Vienna. "However, classical manufacturing methods for vaccines fail to satisfy this demand."
Traditional influenza vaccines, which are produced in embryonated chicken eggs, can be manufactured in the quantities needed for seasonal strains of influenza. Yet because of limited egg supply this method may be insufficient in a pandemic scenario, such as the current H1 N1 'swine flu' pandemic.
The team's new method turns to insect cell based technology to create recombinant influenza virus-like particles (VLPs), which resemble virus particles but lack the viral nucleic acid, so they are not infectious.
The Austrian team took just ten weeks to produce swine-origin pandemic H1N1 influenza VLPs for immunological study in mice. This shows that production of a mock-up vaccine is feasible in this time range, outcompeting conventional production methods which take months.
Using insect cells also bypasses the disadvantages of egg-based production, such as limited production capacity, allergic reactions to egg proteins and biosafety issues.
"Our work demonstrates that recombinant influenza virus-like particles are a very fast, safe and efficient alternative to conventional influenza vaccines and represents a significant new approach for newly emerging influenza strains like swine-origin H1N1 or H5N1" concluded Krammer.
"Virus-like particles will be one solution to tackle the biological variability of influenza pandemics," said journal editor Professor Alois Jungbauer. "Mutated strains can be quickly engineered. So in this respect the teams' work is an extremely valuable contribution to modern vaccine production."
Citation: Florian Krammer, Sabine Nakowitsch, Paul Messner, Dieter Palmberger, Boris Ferko, Reingard Grabherr, 'Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice', Biotechnology Journal Online; doi: 10.1002/biot.200900267
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Why I’ll Talk Policy With Climate Change Deniers But Not Science
- Today's Global Warming Is Nothing Special
- HIP 116454b Shows That Despite Malfunction, Kepler Can Still Find Planets
- Worldwide, Life Expectancy Has Gone Up Over 6 Years Since 1990
- There Was No 'Paleo Diet' - Ancient People Ate What They Had
- Curiosity Detects Spike In Methane, And Other Organic Molecules, On Mars
- You Can Self-identify With Any Ancestry You Want, But Genetically...
- "You spend a great deal of time on the ideological motivations of climate change deniers, but mistakenly..."
- "Or we can blame my mother. It was to be their senior trip in 1959 but Castro and Che Guevara got..."
- "Solution aversion is very real. Talking about solutions which the climate skeptics could live with..."
- "For the avoidance of doubt, as judges are wont to say, it was Buckminster Fuller himself who first..."
- "Thank you for including the Four Myths of Nature. It is very helpful to keep these in mind when..."
- Tooth loss linked to slowing mind and body
- Latest evidence on using hormone replacement therapy for treating menopausal symptoms
- Less than half of UK prescriptions for antipsychotics issued for main licensed conditions
- Don't be tempted to buy your teen a cheap (old) car, parents warned
- The Lancet: Doctor who survived Ebola received experimental drug treatment
Books By Writers Here